Hills Bank & Trust Co. cut its stake in shares of Clorox Co (NYSE:CLX) by 2.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,050 shares of the company’s stock after selling 105 shares during the quarter. Hills Bank & Trust Co.’s holdings in Clorox were worth $650,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in CLX. Athena Capital Advisors LLC purchased a new stake in Clorox in the fourth quarter valued at $25,000. Meeder Asset Management Inc. purchased a new stake in Clorox in the fourth quarter valued at $26,000. Capital Financial Planning LLC purchased a new stake in Clorox in the fourth quarter valued at $32,000. Paragon Capital Management LLC purchased a new stake in Clorox in the first quarter valued at $35,000. Finally, City Holding Co. boosted its holdings in Clorox by 150.0% in the fourth quarter. City Holding Co. now owns 250 shares of the company’s stock valued at $39,000 after purchasing an additional 150 shares during the last quarter. 76.90% of the stock is currently owned by hedge funds and other institutional investors.
In related news, SVP Matthew T. Laszlo sold 10,585 shares of the company’s stock in a transaction dated Wednesday, February 6th. The shares were sold at an average price of $153.89, for a total transaction of $1,628,925.65. Following the completion of the transaction, the senior vice president now owns 17,994 shares in the company, valued at approximately $2,769,096.66. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Andrew J. Mowery sold 5,340 shares of the company’s stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $156.44, for a total transaction of $835,389.60. The disclosure for this sale can be found here. Corporate insiders own 1.40% of the company’s stock.
Shares of Clorox stock opened at $153.01 on Thursday. The stock has a market capitalization of $19.79 billion, a price-to-earnings ratio of 24.44, a PEG ratio of 3.86 and a beta of 0.32. Clorox Co has a fifty-two week low of $113.57 and a fifty-two week high of $167.70. The company has a debt-to-equity ratio of 3.08, a current ratio of 1.15 and a quick ratio of 0.66.
Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, February 4th. The company reported $1.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.32 by $0.08. The business had revenue of $1.47 billion during the quarter, compared to the consensus estimate of $1.47 billion. Clorox had a net margin of 12.65% and a return on equity of 105.97%. The company’s revenue was up 4.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.77 earnings per share. On average, sell-side analysts predict that Clorox Co will post 6.31 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be given a $0.96 dividend. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $3.84 dividend on an annualized basis and a dividend yield of 2.51%. Clorox’s dividend payout ratio (DPR) is currently 61.34%.
Several equities research analysts have commented on the stock. Zacks Investment Research lowered shares of Clorox from a “hold” rating to a “sell” rating in a report on Tuesday, April 9th. Barclays reaffirmed a “hold” rating and issued a $142.00 price target on shares of Clorox in a report on Wednesday, February 6th. Credit Suisse Group assumed coverage on shares of Clorox in a report on Wednesday, March 6th. They issued an “outperform” rating and a $172.00 price target on the stock. Wells Fargo & Co reaffirmed a “hold” rating and issued a $157.00 price target on shares of Clorox in a report on Thursday, February 21st. Finally, BMO Capital Markets set a $175.00 price objective on shares of Clorox and gave the stock a “buy” rating in a research report on Tuesday, February 5th. Six equities research analysts have rated the stock with a sell rating, five have given a hold rating and four have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $151.21.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Story: Does the discount rate affect the economy?
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.